NT-814, a Non-hormonal Dual NK1,3 Receptor Antagonist Markedly Improves Sleep, Mood and Quality of Life in Post-Menopausal Women; Results of a Randomised, Double-Blind, Placebo-Controlled Study (SWITCH-1)

被引:0
|
作者
Joffe, Hadine [2 ,3 ]
Pawsey, Stephen [1 ]
Anderson, Richard [4 ]
Ballantyne, Elizabeth [1 ]
Kerr, Mary [1 ]
Lumsden, Mary Ann [5 ]
Panay, Nicholas [8 ]
Seymore, Susan [1 ]
Simon, James [6 ,7 ]
Trower, Mike [1 ]
机构
[1] KaNDy Therapeut Ltd, Stevenage, Herts, England
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[5] Univ Glasgow, Glasgow, Lanark, Scotland
[6] George Washington Univ, Washington, DC USA
[7] IntimMedicine, Washington, DC USA
[8] Imperial Coll, London, England
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
S-9
引用
收藏
页码:1456 / 1457
页数:2
相关论文
共 2 条
  • [1] NT-814, a Non-Hormonal Dual Neurokinin 1,3 Receptor Antagonist Markedly Improves Hot Flashes in Post-Menopausal Women; Results of a Randomised, Double-Blind, Placebo-Controlled Study
    Simon, James
    Anderson, Richard
    Ballantyne, Elizabeth
    Joffe, Hadine
    Kerr, Mary
    Lumsden, Mary Ann
    Panay, Nicholas
    Seymore, Susan
    Trower, Mike
    Pawsey, Stephen
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1461 - 1461
  • [2] NT-814, a novel dual NK1,3 receptor antagonist results in immediate improvements in bothersome post-menopausal symptoms.
    Pawsey, Stephen
    Ballantyne, Elizabeth
    Trower, Mike
    Kerr, Mary
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (12): : 1492 - 1493